Figure 3From: Clinical and serological evaluation of a novel CENP-A peptide based ELISAAnti-CENP-A reactivity in different disease groups by comparative descriptive analysis. The prevalence and titre of anti-CENP-A measured by CENP-A peptide ELISA was significantly higher in SSc patients compared to controls. Except for rheumatoid arthritis, the anti-CENP-A titres were significantly higher in all disease groups compared to the healthy donors.Back to article page